4 Recruiting Clostridioides Difficile Infection Phase 2 Clinical Trials

Active phase 2 studies for clostridioides difficile infection enrolling across the USA. Verify eligibility and contact site coordinators.

All Clostridioides Difficile Infection studies

Phase 2 Studies for Clostridioides Difficile Infection

🔵 Active, Not Recruiting Phase2 / Phase3

LMN-201 for Prevention of C. Difficile Infection Recurrence

📍 Kaiser Permanente — Escondido, California

View Study & Checklist ➔

🟢 Recruiting Phase2

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

📍 UVA Health Systems — Charlottesville, Virginia

View Study & Checklist ➔

🟢 Recruiting Phase2 / Phase3

Secondary Prevention of Clostridioides Difficile Using Vancomycin

📍 McGill University Health Centre — Montreal, Quebec

View Study & Checklist ➔

🟢 Recruiting Phase2

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

📍 Research Site — Phoenix, Arizona

View Study & Checklist ➔